We are leading a new study to evaluate the safety & effectiveness of #Avutometinib (#Avmapki®) with #abemaciclib (Verzenio®) + #fulvestrant (Faslodex®) in metastatic HR+/HER2- #BreastCancer.

To learn more call 877-338-7425 or visit dana-farber.org/clinical-tri...

Read the new article in #NatureMedicine evaluating the efficacy of #abemaciclib, a cyclin-dependent kinase 4/6 inhibitor, for #meningiomas with somatic NF2 or CDK pathway alterations.

go.nature.com/4jL77cZ

Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort study - Drugs in Context This study aims to enhance comprehension of the clinical efficacy and safety of adjuvant abemaciclib in older women in a real-world setting compared with younger women.

Adjuvant abemaciclib in early-stage breast cancer: hypothesis-generating safety observations from a real-world cohort study

Sottotetti et al.

www.drugsincontext.com/adjuvant-abe...

#MedSky #PharmSky #BreastCancer #Oncology #Abemaciclib #PersonalizedMedicine @medsky.social @me.pharmsky.app

Mayo Clinic researchers have found that #abemaciclib significantly improves survival for people with high-risk, early-stage breast cancer — a major step toward more effective, targeted treatments.
#CancerResearch #BreastCancer #MayoClinic #Oncology #TCSC

newsnetwork.mayoclinic.org/discussion/m...

SALUD. La Comunidad de Madrid participa en "MonarchE", un ensayo clínico de un medicamento contra el cáncer de mama salud, cáncer de mama, medicamentos, MonarchE

SALUD. El ensayo clínico fase 3 MonarchE, donde participa la Comunidad de Madrid, demuestra que añadir abemaciclib a la hormonoterapia reduce significativamente el riesgo de recaída en pacientes de alto riesgo. www.cronicadelhenares.com/2025/10/salu... #MonarchE #CancerDeMama #Abemaciclib #Oncología

Abemaciclib Boosts Survival in High-Risk HR+, HER2- BC Verzenio® (Abemaciclib) improves overall survival in high-risk HR+, HER2- early BC. MonarchE trial results and its impact on treatment.

Press Release: Verzenio (Abemaciclib) Increases Overall Survival in High-Risk HR+, HER2- Early BC.

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Verzenio #Abemaciclib #BC #BreastCancer

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer - OncoDaily ESMO Breast 2025: Imlunestrant + abemaciclib shows PFS benefit in CDK4/6i-pretreated ER+/HER2- advanced breast cancer, per EMBER-3 data.

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EMBER3 #ESMOBreast25 #BreastCancer #Imlunestrant #Abemaciclib

#Medsky #oncosky #pharmasky Among patients with ER+ve #Breastcancer, HER2-ve advanced
BC #imlunestrant led to significantly longer progression-free survival vs standard Tx with ESR1 mutations & #Imlunestrant - #abemaciclib improved progression-free survival vs #imlunestrant alone .

📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer.
🔓https://pubmed.ncbi.nlm.nih.gov/39908010/
@drtimothyerick.bsky.social @nlinmd.bsky.social
@stolaney1.bsky.social

I'm strong, but it's still hard living with the pain of all the treatments/operation that I have been through, but i am grateful to still be here #cancer #breastcancer #chemotherapy #chemo #radiotherapy #tamoxifen #abemaciclib

New JCO 📰 #Abemaciclib Plus #Fulvestrant in Advanced #BreastCancer Following Progression on CDK4/6 Inhibition: Results from the postMONARCH Trial
🔓https://pubmed.ncbi.nlm.nih.gov/39693591/
✍️ @erikahamilton9.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @bastien-nguyen.bsky.social

A little glance at my cancer journey, always happy to answer any questions on #chemo, #coldcaps, #radiotherapy, #masectomy, #abemaciclib, #tamoxifen #breastcancer #cancer